PeptidePedia The community reference

Intention-to-treat analysis: difference between revisions

Diff·revision 8 → 9·19:56, 30 Dec 2024

Difference between revision 8 and revision 9 of Intention-to-treat analysis. 7 lines changed; the page grew by 445 bytes.

Revision 8 — 04:24, 6 Dec 2024
FlowTrialFraser (talk)
the article attributed a finding to the wrong trial in the programme
3,350 bytes +34
Revision 9 — 19:56, 30 Dec 2024
StudentSindhu (talk)
fix indentation in the source
3,795 bytes +445
31| Reference-based imputation | Withdrawers behave like the control group thereafter |31| Reference-based imputation | Withdrawers behave like the control group thereafter |
3232
+33Obesity trials in this field commonly use a reference-based approach for the treatment-policy estimand, which assumes that participants who stop revert towards placebo behaviour — a conservative and reasonably defensible assumption given the [[Weight regain after discontinuation|regain observed after discontinuation]].{{r|ich_e9}}
+34
33== References ==35== References ==
34{{reflist}}36{{reflist}}
36<ref name="hollis1999">Hollis S, Campbell F. "What is meant by intention to treat analysis? Survey of published randomised controlled trials." ''BMJ'' 319(7211):670–674 (1999). PMID 10480822.</ref>38<ref name="hollis1999">Hollis S, Campbell F. "What is meant by intention to treat analysis? Survey of published randomised controlled trials." ''BMJ'' 319(7211):670–674 (1999). PMID 10480822.</ref>
37<ref name="ich_e10">International Council for Harmonisation, ''E10: Choice of Control Group and Related Issues in Clinical Trials'' (2000).</ref>39<ref name="ich_e10">International Council for Harmonisation, ''E10: Choice of Control Group and Related Issues in Clinical Trials'' (2000).</ref>
+40
+41== See also ==
+42* [[Randomised controlled trial]]
+43* [[Placebo-adjusted effect]]
+44* [[Number needed to treat]]
3845
39{{DEFAULTSORT:Intention-to-treat analysis}}46{{DEFAULTSORT:Intention-to-treat analysis}}